Charles Schwab’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,512
Closed -$8.08K 3707
2024
Q1
$8.08K Hold
11,512
﹤0.01% 3467
2023
Q4
$20.1K Hold
11,512
﹤0.01% 3485
2023
Q3
$16.6K Hold
11,512
﹤0.01% 3532
2023
Q2
$29.9K Hold
11,512
﹤0.01% 3509
2023
Q1
$42.4K Buy
+11,512
New +$48.5K ﹤0.01% 3377
2022
Q4
Sell
-10,214
Closed -$41K 3573
2022
Q3
$41K Hold
10,214
﹤0.01% 3379
2022
Q2
$57K Sell
10,214
-53,873
-84% -$441K ﹤0.01% 3378
2022
Q1
$941K Buy
64,087
+2,052
+3% +$27.5K ﹤0.01% 2874
2021
Q4
$981K Sell
62,035
-285
-0.5% -$6.84K ﹤0.01% 2921
2021
Q3
$2M Buy
62,320
+3,247
+5% +$114K ﹤0.01% 2705
2021
Q2
$2.46M Buy
59,073
+28,443
+93% +$1.17M ﹤0.01% 2645
2021
Q1
$1.56M Buy
30,630
+6,407
+26% +$335K ﹤0.01% 2723
2020
Q4
$786K Hold
24,223
﹤0.01% 2844
2020
Q3
$290K Buy
24,223
+6,768
+39% +$78.4K ﹤0.01% 3037
2020
Q2
$231K Buy
+17,455
New +$227K ﹤0.01% 3141

Other funds holding DMTK

Charles Schwab's DMTK Position: Q2 2024 in Review

Charles Schwab sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 11,512 shares — an estimated $8.08K sold.

Charles Schwab first reported a position in DMTK in Q2 2020 and held it in 15 quarters. The position peaked at $2.46M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Charles Schwab reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 11,512 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $8.08K.
  • Charles Schwab first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Charles Schwab's DermTech, Inc. Common Stock position peaked at $2.46M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.